Journal of Molecular Neuroscience

, Volume 17, Issue 2, pp 137–145

Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease



Cell-culture studies have revealed some of the fundamental features of the interaction of amyloid Aβ with cells and the mechanism of amyloid accumulation and pathogenesis in vitro. Aβ1–42, the longer isoform of amyloid that is preferentially concentrated in senile plaque (SP) amyloid deposits in Alzheimer’s disease (AD), is resistant to degradation and accumulates as insoluble aggregates in late endosomes or lysosomes. Once these aggregates have nucleated inside the cell, they grow by the addition of aberrantly folded APP and amyloidgenic fragments of APP, that would otherwise be degraded, onto the amyloid lattice in a fashion analogous to prion replication. This accumulation of heterogeneous aggregated APP fragments and Aβ appears to mimic the pathophysiology of dystrophic neurites, where the same spectrum of components has been identified by immunohistochemistry. In the brain, this residue appears to be released into the extracellular space, possibly by a partially apoptotic mechanism that is restricted to the distal compartments of the neuron. Ultimately, this insoluble residue may be further digested to the protease-resistant Aβn-42 core, perhaps by microglia, where it accumulates as senile plaques. Thus, the dystrophic neurites are likely to be the source of the immediate precursors of amyloid in the senile plaques. This is the opposite of the commonly held view that extracellular accumulation of amyloid induces dystrophic neurites.

Many of the key pathological events of AD may also be directly related to the intracellular accumulation of this insoluble amyloid. The aggregated, intracellular amyloid induces the production of reactive oxygen species (ROS) and lipid peroxidation products and ultimately results in the leakage of the lysosomal membrane. The breakdown of the lysosomal membrane may be a key pathogenic event, leading to the release of heparan sulfate and lysosomal hydrolases into the cytosol. Together, these observations provide the novel view that amyloid deposits and some of the early events of amyloid pathogenesis initiate randomly within single cells in AD. This pathogenic mechanism can explain some of the more enigmatic features of Alzheimer’s pathogenesis, like the focal nature of amyloid plaques, the relationship between amyloid, dystrophic neurites and neurofibrillary-tangle pathology, and the miscompartmentalization of extracellular and cytosolic components observed in AD brain.

Index Entries

Intracellular amyloid Aβ dense bodies dystrophicneurites amyloid accumulation Alzheimer’s pathogenesis lysosomes 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barrow C. J. and Zagorski M. G. (1991) Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179–182.PubMedCrossRefGoogle Scholar
  2. Behl C., et al. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817–827.PubMedCrossRefGoogle Scholar
  3. Bok D. (1993) The retinal pigment epithelium: a versatile partner in vision. J. Cell Sci. 17(Suppl.), 189–195.Google Scholar
  4. Borchelt D. R., et al. (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17(5), 1005–1013.PubMedCrossRefGoogle Scholar
  5. Burdick D., et al. (1992) Assembly and aggregation properties of synthetic Alzheimer’s A4/beta amyloid peptide analogs. J. Biol. Chem. 267(1), 546–554.PubMedGoogle Scholar
  6. Burdick D., et al. (1997) Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer’s amyloid peptide, A beta 1-42, in differentiated PC12 cells. Brain Res. 746(1–2), 275–284.PubMedCrossRefGoogle Scholar
  7. Cai X. D., Golde T. E., and Younkin S. G. (1993) Release of excess amyloid beta protein from a mutant amyloid beta protein precursor [see comments]. Science 259, 514–516.PubMedCrossRefGoogle Scholar
  8. Caporaso G. L., et al. (1994) Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer beta/A4 amyloid precursor protein. J. Neurosci. 14, 3122–3138.PubMedGoogle Scholar
  9. Cataldo A. M., et al. (1990) Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer’s disease: evidence for a neuronal origin. Brain. Res. 513, 181–192.PubMedCrossRefGoogle Scholar
  10. Chartier-Harlin M. C., et al. (1991) Early-onset Alzheimer’s disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353, 844–846.PubMedCrossRefGoogle Scholar
  11. Citron M., et al. (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature 360(6405), 672–674.PubMedCrossRefGoogle Scholar
  12. Citron M., et al. (1994) Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci USA 91(25), 11,993–11,997.CrossRefGoogle Scholar
  13. Citron M., et al. (1997) Mutant presenilins of Alzheimer’s disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice [see comments]. Nat. Med. 3(1), 67–72.PubMedCrossRefGoogle Scholar
  14. Cochran E., et al. (1991) Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer’s disease. Am. J. Pathol. 139, 485–489.PubMedGoogle Scholar
  15. Cole G. M., et al. (1999) Caspase activation in dystrophic neurites in Alzheimer’s Disease and aged HuAPPsw transgenic mice, in Alzheimer’s Disease and Related Disorders (Iqbal K. et al., eds.), John Wiley and Sons, New York, NY, pp. 363–369.Google Scholar
  16. Cras P., et al. (1990) Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer’s disease. Am. J. Pathol. 137, 241–246.PubMedGoogle Scholar
  17. Cummings B. J., Su J. H., and Cotman C. W. (1993) Neuritic involvement within bFGFimmunopositive plaques of Alzheimer’s disease. Exp. Neurol. 124, 315–325.PubMedCrossRefGoogle Scholar
  18. D’Andrea M. R., et al. (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer’s disease. Histopathology 38(2), 120–134.PubMedCrossRefGoogle Scholar
  19. Davies P. (1988) Neurochemical studies: an update on Alzheimer’s disease. J. Clin. Psychiatry 49(Suppl.) 23–28.PubMedGoogle Scholar
  20. Dickson D. W., et al. (1990) Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer’s disease. Acta. Neuropathol. (Berl.) 79, 486–493.CrossRefGoogle Scholar
  21. Dickson D. W., et al. (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer’s disease. Glia 7, 75–83.PubMedCrossRefGoogle Scholar
  22. Duff K., et al. (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383(6602), 710–713.PubMedCrossRefGoogle Scholar
  23. Dyrks T., et al. (1988) Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer’s disease. EMBO J. 7, 949–957.PubMedGoogle Scholar
  24. Eikelenboom P., et al. (1989) Complement activation in amyloid plaques in Alzheimer’s dementia. Virchows. Arch. [B] 56, 259–262.Google Scholar
  25. Friedlich A. L. and Butcher L. L. (1994) Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis. Neurobiol. Aging 15, 443–455.PubMedCrossRefGoogle Scholar
  26. Gajdusek D. C. (1988) Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to beta-pleated sheet configurations. J. Neuroimmunol. 20, 95–110.PubMedCrossRefGoogle Scholar
  27. Glenner G. G. (1989) The pathobiology of Alzheimer’s disease. Annu. Rev. Med. 40, 45–51.PubMedCrossRefGoogle Scholar
  28. Goate A., et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease [see comments]. Nature 349, 704–706.PubMedCrossRefGoogle Scholar
  29. Gouras G. K., et al. (2000) Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156(1), 15–20.PubMedGoogle Scholar
  30. Gregori L., Bhasin R., Goldgaber D. (1994) Ubiquitin-mediated degradative pathway degrades the extra-cellular but not the intracellular form of amyloid beta-protein precursor. Biochem. Biophys. Res. Commun. 203, 1731–1738.PubMedCrossRefGoogle Scholar
  31. Haass C., et al. (1992) Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357(6378), 500–503.PubMedCrossRefGoogle Scholar
  32. Henderson A. S. (1988) The risk factors for Alzheimer’s disease: a review and a hypothesis. Acta. Psychiatr. Scand. 78, 257–275.PubMedGoogle Scholar
  33. Hendriks L., et al. (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat. Genet. 1(3), 218–221.PubMedCrossRefGoogle Scholar
  34. Hilbich C., et al. (1991) Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer’s disease. J. Mol. Biol. 218, 149–163.PubMedCrossRefGoogle Scholar
  35. Hirai S., Tanaka M., and Sotomatsu A. (1990) [Free radicals and degenerative diseases of the nervous system]. Nippon Ronen. Igakkai. Zasshi. 27, 171–176.PubMedGoogle Scholar
  36. Hirano A. (1994) Hirano bodies and related neuronal inclusions. Neuropathol. Appl. Neurobiol. 20, 3–11.PubMedGoogle Scholar
  37. Hung A. Y., et al. (1992) Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc. Natl. Acad. Sci. USA 89(20), 9439–9443.PubMedCrossRefGoogle Scholar
  38. Hyman B. T., et al. (1992) Kunitz protease inhibitor-containing amyloid beta protein precursor immunore-activity in Alzheimer’s disease. J. Neuropathol. Exp. Neurol. 51, 76–83.PubMedGoogle Scholar
  39. Hyman B. T. (1996) Alzheimer’s disease or Alzheimer’s diseases? Clues from molecular epidemiology [editorial]. Ann. Neurol. 40(2), 135–136.PubMedCrossRefGoogle Scholar
  40. Ironside J. W., et al. (1993) Ubiquitin immunocytochemistry in human spongiform encephalopathies. Neuropathol. Appl. Neurobiol. 19, 134–140.PubMedGoogle Scholar
  41. Iwatsubo T., et al. (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13, 45–53.PubMedCrossRefGoogle Scholar
  42. Joachim C., et al. (1991) Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques. Am. J. Pathol. 138, 373–384.PubMedGoogle Scholar
  43. Kalaria R. N. (1993) The immunopathology of Alzheimer’s disease and some related disorders. Brain Pathol. 3, 333–347.PubMedGoogle Scholar
  44. Kimura T., et al. (1995) Are advanced glycation end-products associated with amyloidosis in Alzheimer’s disease? Neuroreport 6, 866–868.PubMedCrossRefGoogle Scholar
  45. Knauer M. F., et al. (1992) Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc. Natl. Acad. Sci. USA 89(16), 7437–7441.PubMedCrossRefGoogle Scholar
  46. Lemere C. A., et al. (1996) The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat. Med. 2(10), 1146–1150.PubMedCrossRefGoogle Scholar
  47. Lowe J., et al. (1990) Ubiquitin conjugate immunoreactivity in the brains of scrapie infected mice. J. Pathol. 162, 61–66.PubMedCrossRefGoogle Scholar
  48. Masliah E., et al. (1991) Immunoelectron microscopic study of synaptic pathology in Alzheimer’s disease. Acta. Neuropathol. (Berl.) 81, 428–433.CrossRefGoogle Scholar
  49. Mattson M. P. (1994) Calcium and neuronal injury in Alzheimer’s disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise. Ann. NY Acad. Sci. 747, 50–76.PubMedCrossRefGoogle Scholar
  50. Mayer R. J., et al. (1996) Endosome-lysosomes, ubiquitin and neurodegeneration. Adv. Exp. Med. Biol. 389, 261–269.PubMedGoogle Scholar
  51. McGeer P. L., et al. (1992) Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy. J. Neurosci. Res. 31, 428–442.PubMedCrossRefGoogle Scholar
  52. McGeer P. L., Rogers J., and McGeer E. G. (1994) Neuroimmune mechanisms in Alzheimer disease pathogenesis [see comments]. Alzheimer Dis. Assoc. Disord. 8, 149–158.PubMedCrossRefGoogle Scholar
  53. Migheli A., et al. (1991) Dystrophic neurites around amyloid plaques of human patients with Gerstmann-Straussler-Scheinker disease contain ubiquitinated inclusions. Neurosci. Lett. 121, 55–58.PubMedCrossRefGoogle Scholar
  54. Miller D. L., et al. (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer’s disease. Arch. Biochem. Biophys. 301, 41–52.PubMedCrossRefGoogle Scholar
  55. Mori H., et al. (1994) Racemization: its biological significance on neuropathogenesis of Alzheimer’s disease. Tohoku. J. Exp. Med. 174, 251–262.PubMedCrossRefGoogle Scholar
  56. Mullan M., et al. (1992) A locus for familial early-onset Alzheimer’s disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat. Genet. 2(4), 340–342.PubMedCrossRefGoogle Scholar
  57. Murphy G. M. Jr., et al. (1992) Alzheimer’s disease. Beta-amyloid precursor protein expression in the nucleus basalis of Meynert. Am. J. Pathol. 141(2), 357–61.PubMedGoogle Scholar
  58. Murrell J., et al. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254, 97–99.PubMedCrossRefGoogle Scholar
  59. Nixon R. A., et al. (1992) The lysosomal system in neurons. Involvement at multiple stages of Alzheimer’s disease pathogenesis. Ann. NY Acad. Sci. 674, 65–88.PubMedCrossRefGoogle Scholar
  60. Nordstedt C., et al. (1994) The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils. J. Biol. Chem. 269, 30,773–30,776.Google Scholar
  61. Omar R., et al. (1993) Acid phosphatase activity in senile plaques and cerebrospinal fluid of patients with Alzheimer’s disease. Arch. Pathol. Lab. Med. 117, 166–169.PubMedGoogle Scholar
  62. Perry G., et al. (1991) Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer’s disease. J. Neurosci. 11, 3679–3683.PubMedGoogle Scholar
  63. Prusiner S. B. and DeArmond S. B. (1987) Prions causing nervous system degeneration. Lab. Invest. 56, 349–363.PubMedGoogle Scholar
  64. Rogers J. (1995) Inflammation as a pathogenic mechanism in Alzheimer’s disease. Arzneimittelforschung 45, 439–442.PubMedGoogle Scholar
  65. Roher A. E., et al. (1993) beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 10,836–10,840.CrossRefGoogle Scholar
  66. Roher A. E., et al. (1993) Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer’s disease. J. Biol. Chem. 268, 3072–3083.PubMedGoogle Scholar
  67. Selkoe D. J. (1986) Altered structural proteins in plaques and tangles: what do they tell us about the biology of Alzheimer’s disease? Neurobiol. Aging 7, 425–432.PubMedCrossRefGoogle Scholar
  68. Selkoe D. J. (2000) Toward a comprehensive theory for Alzheimer’s disease. Hypothesis: Alzheimer’s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. NY Acad. Sci. 924(1), 17–25.PubMedCrossRefGoogle Scholar
  69. Selkoe D. J. (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiolog. Rev. 81(2), 741–766.Google Scholar
  70. Shapira R., Austin G. E., and Mirra S. S. (1988) Neuritic plaque amyloid in Alzheimer’s disease is highly racemized. J. Neurochem. 50, 69–74.PubMedCrossRefGoogle Scholar
  71. Shoji M., et al. (1990) Amyloid beta-protein precursor accumulates in dystrophic neurites of senile plaques in Alzheimer-type dementia. Brain. Res. 512, 164–168.PubMedCrossRefGoogle Scholar
  72. Skovronsky D. M., et al. (2000) In vivo detection of amyloid plaques in a mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 97(13), 7609–7614.PubMedCrossRefGoogle Scholar
  73. Smith M. A., et al. (1994) Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer’s disease. Ann. NY Acad. Sci. 738, 447–454.PubMedCrossRefGoogle Scholar
  74. Smith M. A., et al. (1995) Radical AGEing in Alzheimer’s disease. Trends Neurosci. 18, 172–176.PubMedCrossRefGoogle Scholar
  75. Snow A. D., et al. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer’s disease. Am. J. Pathol. 133, 456–463.PubMedGoogle Scholar
  76. Snow A. D., et al. (1990) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer’s disease and Down’s syndrome. Am. J. Pathol. 137, 1253–1270.PubMedGoogle Scholar
  77. Soreghan B., Kosmoski J., and Glabe C. (1994) Surfactant properties of Alzheimer’s A beta peptides and the mechanism of amyloid aggregation. J. Biol. Chem. 269(46), 28,551–28,554.Google Scholar
  78. Su J. H., Cummings B. J., and Cotman C. W. (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer’s disease. Neuroscience 51, 801–813.PubMedCrossRefGoogle Scholar
  79. Suh Y. H. (1997) An etiological role of amyloidogenic carboxyl-terminal fragments of the beta-amyloid precursor protein in Alzheimer’s disease. J. Neurochem. 68(5), 1781–1791.PubMedCrossRefGoogle Scholar
  80. Suzuki N., et al. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 1336–1340.PubMedCrossRefGoogle Scholar
  81. Tabaton M., et al. (1991) Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. Proc. Natl. Acad. Sci. USA 88, 2098–2102.PubMedCrossRefGoogle Scholar
  82. Tjernberg L. O., et al. (1997) Generation of Alzheimer amyloid beta peptide through nonspecific proteolysis. J. Biol. Chem. 272(3), 1870–5.PubMedCrossRefGoogle Scholar
  83. Tomita T., et al. (1997) The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA 94(5), 2025–2030.PubMedCrossRefGoogle Scholar
  84. Vitek M. P., et al. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 4766–4770.PubMedCrossRefGoogle Scholar
  85. Wisniewski H. M., et al. (1989) Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can. J. Neurol. Sci. 16, 535–542.PubMedGoogle Scholar
  86. Xia W., et al. (1997) Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272(12), 7977–7982.PubMedCrossRefGoogle Scholar
  87. Yamaguchi H., et al. (1992) Ultrastructural localization of Alzheimer amyloid beta/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes. Acta. Neuropathol. (Berl.) 85, 15–22.CrossRefGoogle Scholar
  88. Yamazaki T., et al. (1991) Ultrastructural localization of argyrophilic substances in diffuse plaques of Alzheimer-type dementia demonstrated by methenamine silver staining. Acta. Neuropathol. (Berl.) 81, 540–545.CrossRefGoogle Scholar
  89. Yang A. J., et al. (1995) Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J. Biol. Chem. 270(24), 14,786–14,792.Google Scholar
  90. Yang A. J., et al. (1998) Loss of endosomal/lysosmal membrane impermeability is an early event in amyloid Aβ1-42 pathogenesis. J. Neurosci. Res. 52, 691–698.PubMedCrossRefGoogle Scholar
  91. Yasuhara O., et al. (1994) Two types of dystrophic neurites in senile plaques of Alzheimer disease and elderly non-demented cases. Neurosci. Lett. 171, 73–76.PubMedCrossRefGoogle Scholar
  92. Younkin S. G. (1995) Evidence that A beta 42 is the real culprit in Alzheimer’s disease [editorial; comment]. Ann. Neurol. 37, 287–288.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2001

Authors and Affiliations

  1. 1.Department of Molecular Biology and BiochemistryUniversity of California, IrvineIrvine

Personalised recommendations